SBIR-STTR Award

Automated Daily Dose Reconstruction And Delivery Verification For External Beam Radiotherapy
Award last edited on: 10/27/14

Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$214,158
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Nathan Childress

Company Information

Mobius Medical Systems LP

5012 Tamarisk Street
Bellaire, TX 77401
   (713) 234-0123
   sales@mobiusmed.com
   www.mobiusmed.com
Location: Single
Congr. District: 07
County: Harris

Phase I

Contract Number: 1R43CA189303-01A1
Start Date: 9/19/14    Completed: 3/18/15
Phase I year
2014
Phase I Amount
$214,158
Approximately half of the 1.6 million people diagnosed with cancer in 2013 in the United States will receive radiation therapy in the management of their disease. Because each course of radiation therapy is tailored to the disease and anatomy of the patient, delivery of the intended dose is dependent upon, in part, the ability of the treatment machine to reproduce the planned treatment parameters. Despite this, the current quality assurance paradigm in radiation oncology does not provide independent verification that the plan has been correctly delivery each time the patient has been treated. Indeed, current practice is largely dependent upon internal safeguards deployed by the linear accelerator manufacturer to recognize meaningful system deviations and terminate delivery accordingly. The motivation for this application is an urgent need for commercial tools that improve confidence in daily treatment of every radiation therapy patient. The overarching hypothesis of this proposal is that treatment delivery log files produced by the treatment delivery system can be combined with an independent dose calculation algorithm, and, eventually, patient positioning information to provide daily verificatin of the delivered dose and significantly improve estimates of the dose received by the patient. The system will provide significant enhancements in patient safety in radiation therapy, and will have important applications in adaptive therapy, performance monitoring, and statistical process control. The Phase I goals are to (i) to demonstrate the feasibility of the system to provide accurate estimates of the daily delivered dose and (ii) to build a framework for incorporating future extensions, such as incorporating daily localization images, in the daily dose reconstruction process. The proposed system will be developed using sample data collected from our academic partner. Treatment delivery data will be extracted from linear accelerator log files and passed to an independent dose calculation algorithm. The resulting 3D dose distribution will be calculated and compared with the planned distribution. The user will then be automatically notified if pre-determined dosimetric thresholds set by the user are exceeded. The clinical functionality of the system will be assessed through deployment in the clinical setting and the accuracy of the system will be assessed by comparing its dose calculations with simultaneous physical measurements of the delivered dose distribution. !

Public Health Relevance Statement:


Public Health Relevance:
This application proposes to develop a novel and efficient software product that verifies radiation treatments of cancer patients have been delivered as intended. Using electronic data generated by the delivery system during treatment, this product will enable, for the first time, fully automated calculation of the three-dimensional radiation dose pattern received by the patient each day. The proposed application has applications not only in patient safety, but will also serve an important role in daily adaptive radiation therapy, a current area of high research activity in radiation oncology.

Project Terms:
abstracting; Agreement; Algorithms; American; Anatomy; Area; Cancer Patient; Clinic; Clinical; cohort; Collimator; Complex; Computer software; Coupled; Data; Development; Devices; Diagnosis; Disease; Dose; electronic data; Environment; Future; Goals; Head and neck structure; Hour; Image; improved; Interruption; Linear Accelerator Radiotherapy Systems; Lung; Malignant neoplasm of prostate; Malignant Neoplasms; Manufacturer Name; Measurement; Measures; Medicine; Memory; Methods; Metric; Monitor; Motivation; novel; Outcome; patient safety; Patients; Pattern; Performance; Phase; Positioning Attribute; Process; public health relevance; quality assurance; Radiation; Radiation Oncology; Radiation therapy; reconstruction; Research Activity; Role; Sampling; System; Testing; Time; tool; treatment planning; United States; Variant

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----